NCT01569607

Brief Summary

Stroke is a leading cause of morbidity in the United States but identification of treatment strategies to improve outcome is limited by the incomplete understanding of the mechanisms of recovery. Motor cortex (M1) reorganization plays a major-role in the recovery of motor deficits post-stroke; hence the importance for further development of rehabilitative strategies that utilize this potential for recovery. In Specific Aim 1, investigators will determine if repeated exposure to training combined with Hebbian-type M1 stimulation enhances functional M1 reorganization in lesioned M1 of stroke patients. In Specific Aim 2, investigators will determine if repeated exposure to training combined with Hebbian-type M1 stimulation enhances structural cortical reorganization in lesioned M1 of stroke patients and to explore whether these structural changes are related to the training induced functional cortical reorganization. The overall goal of this project is to determine the effect of Hebbian- type stimulation on both, functional and structural brain reorganization, thereby obtaining indirect evidence for the neuronal substrate underlying training related improvement and maintenance of motor function in stroke patients. This knowledge may have a substantial positive impact on treatment for stroke patients that may significantly improve recovery and could move the field of neuro-rehabilitation forward.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Mar 2012

Longer than P75 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 8, 2012

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

March 30, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 3, 2012

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 26, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 26, 2016

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

January 16, 2018

Completed
Last Updated

January 16, 2018

Status Verified

December 1, 2017

Enrollment Period

4.5 years

First QC Date

March 30, 2012

Results QC Date

October 31, 2017

Last Update Submit

December 13, 2017

Conditions

Keywords

NeurophysiologyTranscranial Magnetic Stimulation (TMS)NeurologyStrokePhysical Medicine and Rehabilitation

Outcome Measures

Primary Outcomes (1)

  • Primary Motor Cortex (M1) Excitability Derived From Stimulus Response Curve

    Motor evoked potential (MEP) amplitudes were measured prior to treatment (baseline), one week after the treatment (post-training 1), and 4 weeks after treatment (post-training 2).The MEP is elicited by transcranial magnetic stimulation (TMS) at increased intensity. Its amplitude is measured from peak to peak and expressed in millivolts (mV). Measured MEP amplitudes were plotted against the intensity to create a stimulus response curve (SRC). Long-lasting increases in MEP amplitude indicate increases in motor cortex excitability and are associated with motor learning.

    Baseline, Post-Training 1 (1 Week), Post-Training 2 (4 Weeks)

Secondary Outcomes (8)

  • Mean Time to Completion for Jebsen Hand Function Test (JTT)

    Baseline, Post-Training (1 Week), Post-Training (4 Weeks)

  • Mean Peak Acceleration of Wrist Extension Movements

    Baseline, Post-Training (1 Week), Post-Training (4 Weeks)

  • Mean Reaction Time of Wrist Extension Movements

    Baseline, Post-Training (1 Week), Post-Training (4 Weeks)

  • Mean Motor Activity Log (MAL) Score: Amount Subtest

    Baseline, Post-Training (1 Week), Post-Training (4 Weeks)

  • Mean Motor Activity Log (MAL): How Well Subtest

    Baseline, Post-Training (1 Week), Post-Training (4 Weeks)

  • +3 more secondary outcomes

Study Arms (2)

Hebbian-type Stimulation

EXPERIMENTAL

Participants will be randomized to receive motor training with Hebbian-type stimulation.

Device: Repetitive Transcranial Magnetic Stimulation (rTMS)

Sham Stimulation

SHAM COMPARATOR

Participants will be randomized to receive sham stimulation.

Device: Sham stimulation

Interventions

Training sessions for 5 days in a row

Hebbian-type Stimulation

Sham stimulation

Sham Stimulation

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-85
  • Single cerebral ischemic infarction \> 6 month affecting the primary motor output system of the hand at a cortical (M1) level as defined by MRI of the brain
  • At the time of cerebral infarct a motor deficit of hand of MRC of \<4- of wrist and finger extension/flexion movement
  • Good recovery of hand function as defined by MRC of 4 or 4+ of wrist- and finger extension/flexion movements
  • Ability to perform wrist extension movements
  • No other neurological disorder
  • No intake of CNS active drugs
  • Ability to give informed consent
  • No major cognitive impairment
  • No contraindication to TMS or MRI

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emory University School of Medicine

Atlanta, Georgia, 30322, United States

Location

Related Publications (1)

  • Revill KP, Haut MW, Belagaje SR, Nahab F, Drake D, Buetefisch CM. Hebbian-Type Primary Motor Cortex Stimulation: A Potential Treatment of Impaired Hand Function in Chronic Stroke Patients. Neurorehabil Neural Repair. 2020 Feb;34(2):159-171. doi: 10.1177/1545968319899911. Epub 2020 Jan 24.

MeSH Terms

Conditions

Stroke

Interventions

Transcranial Magnetic Stimulation

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Magnetic Field TherapyTherapeutics

Results Point of Contact

Title
Dr. Cathrin Buetefisch
Organization
Emory University

Study Officials

  • Cathrin Buetefisch, MD, PhD

    Emory University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Dr. Cathrin Buetefisch, MD, PhD

Study Record Dates

First Submitted

March 30, 2012

First Posted

April 3, 2012

Study Start

March 8, 2012

Primary Completion

August 26, 2016

Study Completion

August 26, 2016

Last Updated

January 16, 2018

Results First Posted

January 16, 2018

Record last verified: 2017-12

Locations